Clinical Trial Update: Bone Effects of Teriparatide Following Alendronate [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the bone effects of teriparatide after alendronate therapy for osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Teriparatide (Teriparatide)
• alendronate (alendronate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED